x

Cerca una sperimentazione clinica

* (*) campo obbligatorio

242 Risultato/i

Ordinato per

Sperimentazione in fase di reclutamento = Sperimentazione in fase di reclutamento
; Sperimentazione in corso = Sperimentazione in corso
; Finanziato da un ente associato a IRDiRC =

Sperimentazioni cliniche nazionali

FRANCIA

AUVERGNE-RHONE-ALPES
GRENOBLE

FRANCIA

ILE-DE-FRANCE
PARIS

Phase III study chemotherapy vs radiotherapy in low-grade glioma
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Service de Neurologie 2 (Mazarin) : Unité d'Onco-Neurologie

GERMANIA

Bayern
REGENSBURG

GERMANIA

Nordrhein-Westfalen
BONN

AUSTRIA

WIEN
WIEN

SIOP-LGG-2004: Cooperative Multicenter Study for Children and Adolescents With Low Grade Glioma (Phase III) - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Neonatologie, Pädiatrische Intensivmedizin und Neuropädiatrie

AUSTRIA

WIEN
WIEN

Sperimentazione in fase di reclutamento
Sperimentazione in corso
VINILO: Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Neonatologie, Pädiatrische Intensivmedizin und Neuropädiatrie

FRANCIA

AUVERGNE-RHONE-ALPES
LYON

FRANCIA

ILE-DE-FRANCE
PARIS

Sperimentazione in fase di reclutamento
Sperimentazione in corso
A Study Evaluating Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia. A Phase III Double-blind Randomized Placebo-controlled Trial
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Unité Fonctionnelle Epilepsie

FRANCIA

ILE-DE-FRANCE
PARIS

DXA : A Study Evaluating Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia. A Phase III Double-blind Randomized Placebo-controlled Trial
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Service de Neurologie 2 (Mazarin) : Unité d'Onco-Neurologie

FRANCIA

ILE-DE-FRANCE
VILLEJUIF

Sperimentazione in fase di reclutamento
Cooperative multicenter study for children and adolescents with low grade glioma - FR
CLCC Institut Gustave Roussy
Département de Cancérologie de l'enfant et de l'adolescent

FRANCIA

ILE-DE-FRANCE
VILLEJUIF

Sperimentazione in fase di reclutamento
Sperimentazione in corso
BIOMEDE: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication (Phase II) - FR
CLCC Institut Gustave Roussy
Département de Cancérologie de l'enfant et de l'adolescent

FRANCIA

ILE-DE-FRANCE
VILLEJUIF

FRANCIA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

IRLANDA

County Dublin
DUBLIN

A Phase II Multi-Centre Study of Concomitant and Prolonged Adjuvant Temozolomide With Radiotherapy in Diffuse Pontine Gliomas - IE
Our Lady's Children's Hospital
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

ITALIA

LOMBARDIA
MILANO

Sperimentazione in fase di reclutamento
Sperimentazione in corso
Studio clinico di Fase II, in aperto, monocentrico, non controllato, non randomizzato, sulla Fluoresceina Sodica nella Chirurgia dei Gliomi di alto Grado
Fondazione IRCCS Istituto Neurologico "Carlo Besta"
UOC Neurochirurgia 2 - Neurochirurgia Vascolare

POLONIA

Warszawa
WARSAW

Sperimentazione in fase di reclutamento
Sperimentazione in corso
Cooperative Multicenter Study for Children and Adolescents With Low Grade Glioma - PL
Instytut "Pomnik-Centrum Zdrowia Dziecka"
Klinika Onkologii IP-CZD

PORTOGALLO

NORTE
PORTO

Sperimentazione in fase di reclutamento
Sperimentazione in corso
Cooperative Multicenter Study for Children and Adolescents With Low Grade Glioma - PT
Centro Hospitalar de S. João, EPE
Unidade de Hematologia e Oncologia Pediátrica

REGNO UNITO; GRAN BRETAGNA

Nottinghamshire
NOTTINGHAM

REGNO UNITO; GRAN BRETAGNA

Tyne & Wear
NEWCASTLE UPON TYNE

CNS 2007 04: A Phase II Multi-Centre Study of Concomitant and Prolonged Adjuvant Temozolomide With Radiotherapy in Diffuse Pontine Gliomas - UK (Completed)
The Great North Children's Hospital, Royal Victoria Infirmary
Sir James Spence Institute of Child Health

REGNO UNITO; GRAN BRETAGNA

West Yorkshire
LEEDS

BELGIO

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

BELGIO

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Sperimentazione in fase di reclutamento
Sperimentazione in corso
Phase II Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma
Universitair Ziekenhuis Brussel - UZ Brussel
Universitair Ziekenhuis Brussel (UZ Brussel)

FRANCIA

AUVERGNE-RHONE-ALPES
BRON

Sperimentazione in fase di reclutamento
Sperimentazione in corso
Randomized, Prospective, Multicenter Blinding Singles With Arm A and Arm B Innovative Strategy Strategy Conventional (Phase III) - FR
CHU de Lyon HCL - GH Est-Hôpital Neurologique P. Wertheimer
Neurochirurgie B - Unité multidisciplinaire de Chirurgie Tumorale de la base du Crâne

FRANCIA

BRETAGNE
RENNES

FRANCIA

ILE-DE-FRANCE
BOBIGNY

A Phase II multicenter study of immunotherapy with CpG-ODN in patients with glioblastoma -Terminated -
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de Neurologie

FRANCIA

ILE-DE-FRANCE
BOBIGNY

Randomized Phase III Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma - Terminated -
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de Neurologie

FRANCIA

ILE-DE-FRANCE
BOBIGNY

Glivec - Hydrea in recurrent glioblastoma (Phase II) - Terminated -
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de Neurologie

FRANCIA

ILE-DE-FRANCE
BOBIGNY

Sperimentazione in fase di reclutamento
Radiotherapy and Temozolomide with or without Avastin for treatment of de novo glioblastoma (Phase III)
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de Neurologie

FRANCIA

ILE-DE-FRANCE
BOBIGNY

FRANCIA

ILE-DE-FRANCE
PARIS

EORTC protocol 26083 : Randomized phase II of CCNU (Lomustine) versus CCNU (Lomustine) - dasatinib in patients with recurrent glioblastoma
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Unité Fonctionnelle Epilepsie

FRANCIA

ILE-DE-FRANCE
PARIS

Sperimentazione in fase di reclutamento
Multicentric Randomized Phase II: Immunotherapy With CpG-ODN in Malignant Glioblastoma
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Consultation de Neurochirurgie

FRANCIA

ILE-DE-FRANCE
PARIS

Chemotherapy study of temozolomide-bevacizumab treatment of supratentorial glioblastoma patients more than 70 years old with altered functional state (Phase II).
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Service de Neurologie 2 (Mazarin) : Unité d'Onco-Neurologie

FRANCIA

ILE-DE-FRANCE
PARIS

Sperimentazione in fase di reclutamento
Sperimentazione in corso
A Prospective, Multi-center Phase III Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed Glioblastoma Multiforme
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Service de Neurologie 2 (Mazarin) : Unité d'Onco-Neurologie

FRANCIA

ILE-DE-FRANCE
PARIS

Sperimentazione in fase di reclutamento
Sperimentazione in corso
ONCOVIRAC : Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients (Phase I-II)
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Service de Neurologie 2 (Mazarin) : Unité d'Onco-Neurologie

FRANCIA

ILE-DE-FRANCE
PARIS

Phase I/II study of S49076, a multi-target inhibitor of c-MET, AXL, FGFR in combination with bevacizumab in patients with recurrent glioblastoma multiforme - FR
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Service de Neurologie 2 (Mazarin) : Unité d'Onco-Neurologie

FRANCIA

OCCITANIE
TOULOUSE

PhaseI-II trial to assess the radiosensitizing effect of Zarnestra in patients with glioblastoma multiforme
IUCT Oncopole - CLCC Institut Claudius Regaud
Département de radiothérapie

FRANCIA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

A randomized multicentric phase II trial immunotherapy of de novo glioblastoma by CpG-ODN
CHU de Marseille - Hôpital de la Timone
Service de Neuro-oncologie

GERMANIA

Baden-Württemberg
HEIDELBERG

GERMANIA

Baden-Württemberg
HEIDELBERG

GERMANIA

Baden-Württemberg
HEIDELBERG

GERMANIA

Baden-Württemberg
HEIDELBERG

GERMANIA

Bayern
MÜNCHEN

Sperimentazione in fase di reclutamento
Sperimentazione in corso
GlioCave/NOA17: Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma (Phase 2) - DE
Klinikum rechts der Isar der Technischen Universität München
Klinik und Poliklinik für RadioOnkologie und Strahlentherapie

GERMANIA

Berlin
BERLIN

Sperimentazione in fase di reclutamento
Sperimentazione in corso
The C-GBM Study: Prospective controlled phase II trial of Cabazitaxel in patients with Temozolomide refractory Glioblastoma Multiforme - DE
Charité - Universitätsmedizin Berlin (CVK)
Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie

GERMANIA

Hamburg
HAMBURG

Sperimentazione in corso
Phase 3b Study for Management of Ocular Side Effects in Subjects With EGFR-amplified Glioblastoma Receiving Depatuxizumab Mafodotin (ABT-414) -DE-
Hubertus Wald Tumorzentrum/ Universitäres Cancer Center (UCCH)
Comprehensive Cancer Center (CCC) Hamburg

GERMANIA

Nordrhein-Westfalen
BONN

NOA-05: Phase II trial of Procarbazine and Lomustine in Gliomatosis cerebri - Terminated
Universitätsklinikum Bonn (AöR)
Klinik und Poliklinik für Neurologie

PAESI BASSI

Noord-Holland
AMSTERDAM

PAESI BASSI

Zuid-Holland
ROTTERDAM

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

REGNO UNITO; GRAN BRETAGNA

Greater Manchester
ADDRESS: NOT PROVIDED - UK

SPAGNA

Cataluña
BADALONA

SPAGNA

Navarra
PAMPLONA

Phase II study of neoadjuvant nivolumab in patients with glioblastoma multiforme - ES (completed)
CIMA - Centro de Investigación Médica Aplicada
Área de Terapia Génica y Hepatología

SVIZZERA

Suisse Alémanique
ZÜRICH

Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma (ARTE)
University Hospital Zurich
Department of Neurology

BELGIO

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Sperimentazione in corso
STEP: Sorafenib Long Term Extension Program - BE
Cliniques Universitaires UCL Saint-Luc
Pneumologie_Oncologie thoracique

Sperimentazioni cliniche internazionali

REGNO UNITO; GRAN BRETAGNA

Leicestershire
LEICESTER

Sperimentazione in corso
CNS 2004 03: Cooperative Multicentre Study For Children And Adolescents With Low Grade Glioma (Phase III) (coordination)
Leicester Univ. Hosp. NHS - Leicester Royal Infirmary
University Hospitals of Leicester NHS Trust Headquarters

BELGIO

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

BELGIO

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

BELGIO

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Sperimentazione in corso
Finanziato da un ente associato a IRDiRCIWOT: IDH mutated 1p/19q intact lower grade glioma following resection: Wait Or Treat? - A phase III study
EORTC
European Organisation for the Research and Treatment of Cancer

GERMANIA

Baden-Württemberg
TÜBINGEN